MedPath
TGA Approval

PALEXIA SR tapentadol (as hydrochloride) 250 mg sustained release tablet blister pack (165357)

165357

PALEXIA SR tapentadol (as hydrochloride) 250 mg sustained release tablet blister pack

Seqirus Pty Ltd

January 19, 2011

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/4bdcfca2622d1af858a5d3a3fc0a8e27.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/9ca78817f17e8afac4448c25c16ba7c2.pdf

Active Ingredients

tapentadol hydrochloride

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

PALEXIA SR tapentadol (as hydrochloride) 250 mg sustained release tablet blister pack (165357) - TGA 批准文号 | MedPath